Cite
HARVARD Citation
Morath, C. et al. (2022). Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial. BMJ open. 12 (11), p. . [Online].